Table 1.
Demographics and clinical data of studied ADNI subjects at baseline.
| CN (n = 193) |
LMCI (n = 357) |
AD (n = 172) |
p-value | |
|---|---|---|---|---|
| Age, year M (SD) | 75.60 (4.90) | 74.71 (7.44) | 75.09 (7.35) | 0.84 |
| Sex, Female % (n) | 50% (96) | 35% (126) | 49% (84) | <0.001 |
| APOE ε4, % (n) | 28% (54) | 53% (189) | 67% (115) | <0.001 |
| MMSE, M (SD) | 29.17 (0.96) | 26.96 (1.81) | 23.44 (2.00) | <0.0001 |
| ADAS-Cog13, M (SD) | 9.33 (4.16) | 18.61 (6.32) | 28.57 (7.66) | <0.0001 |
Abbreviations: AD-Alzheimer’s Disease; ADAS-Cog13: Alzheimer’s Disease Assessment Scale-Cognitive subscale; CN-cognitively normal, MMSE-Mini-Mental State Exam, LMCI-late mild cognitive impairment.